Brief reports
Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology

https://doi.org/10.1016/S0002-9149(02)03328-3Get rights and content

First page preview

First page preview
Click to open first page preview

References (15)

  • N.F. Voelkel et al.

    Primary pulmonary hypertension between inflammation and cancer

    Chest

    (1998)
  • L.J. Rubin et al.

    Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

    Ann Intern Med

    (1990)
  • R.J. Barst et al.

    A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

    N Engl J Med

    (1996)
  • R.J. Barst et al.

    Vasodilator therapy for primary pulmonary hypertension in children

    Circulation

    (1999)
  • E.B. Rosenzweig et al.

    Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects

    Circulation

    (1999)
  • M. Rabinovitch et al.

    Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue

    Hum Pathol

    (1980)
  • S. Archer et al.

    Primary pulmonary hypertensiona vascular biology and translational research “work in progress”

    Circulation

    (2000)
There are more references available in the full text version of this article.

Cited by (0)

View full text